AstraZeneca to buy cell therapy biotech for up to $1 billion

AstraZeneca

Source: Fortune

AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies said.

Go to Source

Related News

APP

Design by

This site uses cookies from Fews App to deliver its services, to personalize ads and to analyze traffic. Information about your use of this website is shared with Fews App. By using this site, you agree to its use of cookies.

GOT IT

LEARN MORE

Thank you for subscribing our newsletter

Your email has already been added to our subscibers list

Invalid email

News

World

Audio News

News

World

Audio News

AstraZeneca to buy cell therapy biotech for up to $1 billion